Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment

medRxiv(2020)10.1101/2020.02.03.20019786Source: DataRank Database

Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (46)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Kayleen Brien,James Millard ORCID,Alison D. Grant ORCID,Nesri Padayatchi ORCID,Alexander S. Pym ORCID

Live enrichment

PubMed:19767382 OpenAlex:https://openalex.org/W3005359594

Wellcome Trust

Grant: 203919

Health Priorities in Resource-Limited Settings

UK Research and Innovation

Grant: MR/P007597/1

An integrated approach to understand the emergence and spread of extensively resistant Gram-negative bacteria in China

UK Research and Innovation

Grant: BB/R01356X/1

UCL Biosciences Big Data

National Institutes of Health

Grant: 1R01AI124413-01

Promoting Engagement in the Drug Resistant TB/HIV Care Continuum in South Africa

Wellcome Trust

Grant: 203583

Understanding within-patient Mycobacterium tuberculosis genetic diversity to prevent drug-resistance

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2020/03/03/2020.02.03.20019786.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.02.03.20019786

repositoryhttps://doi.org/10.1101/2020.02.03.20019786

https://doi.org/10.1016/j.ebiom.2020.102747

Fields of Study

Tuberculosis Research and EpidemiologyMycobacterium research and diagnosisAntibiotic Resistance in Bacteria0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

BedaquilineMycobacterium tuberculosisGenetic diversityBiologyAntibiotic resistanceTuberculosisSputumDrug resistanceWhole genome sequencingAntibioticsGeneticsMedicineGenomePopulationPathologyGeneAdultMaleMedicine (General)Research paperAntitubercular AgentsMicrobial Sensitivity TestsCohort StudiesSouth AfricaR5-920Drug Resistance, Multiple, BacterialHumansDiarylquinolinesRGenetic VariationGene Expression Regulation, BacterialMiddle AgedTBGenes, BacterialHost-Pathogen InteractionsHeteroresistanceFemaleRifampinMetabolic Networks and PathwaysFluoroquinolones

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being